Patent intelligence · CA
CA 2723411
PROCEDE
PROCEDE
Patent details — CA 2723411
- Jurisdiction
- CA
- Status
- granted
- Grant date
- Nov 12, 2009
- Expiration
- Nov 7, 2029
- Applicant
- BIAL PORTELA & COMPANHIA S A [PT]
- CPC classes
- A61P/4300, A61P/900, A61P/910
Quick answer
CA 2723411 (PROCEDE) is held by BIAL PORTELA & COMPANHIA S A [PT]. Status: granted. Granted Nov 12, 2009. Expires Nov 7, 2029 (3 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIAL PORTELA & COMPANHIA S A [PT]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61P/4300, A61P/900, A61P/910
More from BIAL PORTELA & COMPANHIA S A [PT]
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 2723411?
CA 2723411 (PROCEDE) is held by BIAL PORTELA & COMPANHIA S A [PT]. Status: granted. Granted Nov 12, 2009. Expires Nov 7, 2029 (3 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CA 2723411?
BIAL PORTELA & COMPANHIA S A [PT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3 pharmaceutical patents for this assignee.
When does CA 2723411 expire?
Our index shows an expiration date of Nov 7, 2029 (3 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.